U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07435987) titled 'Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy' on Jan. 29.

Brief Summary: This prospective, non-randomised, single centre, phase I trial assesses the clinical feasibility of the use of the patient-tailored ARCHITECT applicator in locally advanced cervical cancer brachytherapy.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Locally Advanced Cervical Cancer Uterine Carcinoma

Intervention: DEVICE: ARCHITECT applicator

Patient-tailored, 3D-printed applicator

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Erasmus Medical Center

Information provided by (Responsible Party): ...